Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

IND accepted for phase I study of CPP-109 for treating cocaine addition

Jan. 10, 2005

USAMRIID awards grant to Lexicon for ricin biodefense efforts

Jan. 4, 2005

Standard and novel mGluR5 antagonists in the treatment of cocaine addiction

Jan. 3, 2005

Finasteride tested to treat alcoholism

Dec. 30, 2004

5-HT1B receptors are involved in cocaine sensitization

Dec. 28, 2004

ICL-670 effective in treating iron overload

Dec. 16, 2004

Aerosolized Radilex superior to muscle injection following radiation exposure

Dec. 15, 2004

Buprenorphine analogue inhibits morphine-induced behavioral sensitization in mice

Dec. 10, 2004

RiVax, first ricin vaccine to enter human clinical trials

Dec. 2, 2004

Tetrodin studied in phase II trial of opiate-dependent subjects

Nov. 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...